SURGICAL CONSIDERATIONS
Description: The most common indication for
postpartum uterine devascularization and hysterectomy is
intractable postpartum hemorrhage (
PPH). PPH is clinically defined as any uncompensated postpartum blood loss → tissue hypoperfusion. There are four major causes of PPH: retained products of conception (POC), laceration of the genital tract, uterine atony, and coagulopathies. Inherited coagulopathies include von Willebrand’s disease,
hemophilia, and factor XI deficiency. Acquired coagulopathies are most often related to thrombocytopenia 2° preeclampsia/eclampsia, hypofibrinogenemia 2° long-standing fetal demise, placental abruption, and DIC related to massive blood loss.
Postpartum blood loss can be reduced by prophylactic use of oxytocin, methylergonovine, or prostaglandins, and these same agents are used as the first line of treatment for PPH. A concentrated oxytocin infusion (e.g., 80-100 U in 500 mL over 30 min) may be used. Methylergonovine should be given im only (0.2 mg q 2-4 h up to 1 mg) because iv infusion has been reported to cause acute HTN, stroke, and Sz. Ergot derivatives are contraindicated in patients with Hx of HTN, asthma, Raynaud’s syndrome, or migraine. PGF2α (Hemabate) may be injected im (intramyometrial) at a dose of 0.25 mg, up to a total of 2 mg. Misoprostol, an inexpensive PGE, may be given rectally (up to 800 mcg).
Simultaneously, the surgeon should explore the cause of PPH and apply a specific treatment. If PPH is not controlled with treatment of uterine atony, and after volume replacement and correction of any coagulopathy, temporizing measures should be applied while preparing the patient for definitive invasive treatments. Temporizing measures include packing of uterine cavity with a long gauze and use of balloon tamponade. Extensive experience on nonpneumatic antishock garment (ASG) on nonpregnant patients is applied to postpartum patients with remarkable success in temporizing hypovolemic shock from abdominal and pelvic bleeding. ASG can be applied quickly and results in an immediate 1500-2000 mL autotransfusion. ASG should not be used with fetus in situ or thoracic site of hemorrhage. After stabilization, patient should be transferred to radiology for uterine artery embolization under fluoroscopic control where uterine arteries are selected and absorbable Gelfoam pledgets are introduced. Treatment may be repeated until bleeding is stopped. In known cases of placenta accreta, in anticipation of PPH, catheters have been placed in uterine arteries before C-section.
If selective embolization is not available or fails to stop hemorrhage, more invasive surgical intervention should be employed, including uterine compression sutures, iliac artery ligation, uterine devascularization, and hysterectomy. The decision for surgical intervention is made when other options (i.e., medical, interventional radiology) have not been successful in decreasing the hemorrhage. Volume and coagulation factor replacement should continue while proceeding with surgery.
The technique for an emergent obstetrical hysterectomy is largely similar to a hysterectomy for other indications. Of note is the engorged and prominent nature of the vessels supplying the gravid uterus. The edematous tissues surrounding the uterus are very friable and may bleed profusely if improperly manipulated. A supracervical or total hysterectomy may be performed. Through a midline or Pfannenstiel’s incision, the uterus is elevated out of the abdominal cavity. The round ligaments are clamped, transected, and ligated; and the anterior leaf of the broad ligament is incised bilaterally from the transected round ligaments to the vesicouterine reflection. The posterior leaf of the broad ligament adjacent to the uterus is entered at a level just below that of the fallopian tubes and uteroovarian ligaments. These are then clamped, transected, and ligated. Next, incision of the posterior leaf of the broad ligament toward the cardinal ligaments is performed. With gentle blunt dissection, the bladder and attached vesicouterine peritoneal flap are dissected off the lower uterine segment. The ascending uterine arteries and veins are identified bilaterally, then clamped, transected, and ligated. If a subtotal hysterectomy is planned, the body of the uterus is amputated at this level, and the cervical stump is closed with interrupted sutures. If a total hysterectomy is planned, dissection of the bladder off the cervix is continued until the cervicovaginal margin is identified. The cardinal and uterosacral ligaments are clamped, transected, and ligated, with clamps placed as close to the cervix as possible without including cervical tissue. After the level of the lateral vaginal fornix is reached, a clamp is swung below the cervix, across the lateral vaginal fornix. The cervix is then amputated off the vaginal cuff. Throughout the procedure, it is vital to clamp and ligate any bleeding vessels and to take extra care to avoid damage to the ureter or bladder. Following removal of the uterus and cervix, the vaginal cuff angles are sutured to the ipsilateral cardinal ligament stumps, and the vaginal cuff is closed with a running locked stitch. The abdominal wall is closed in layers.
Usual preop diagnosis: Intractable postpartum bleeding; rupture of gravid uterus
Suggested Readings
1. AbdRabbo SA: Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol 1994; 171:694-700.
2. B-Lynch C, Coker A, Lawal AH, et al: The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynecol 1997; 104:372-5.
3. Bukowski R, Hankins GDV: Managing postpartum hemorrhage. Contemporary OB/GYN 2001; 9:92-105.
4. Cho JH, Jun HS, Lee CN: Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol 2000; 96(1):129-31.
5. Cunningham FG, MacDonald PC, Gant NF, et al: Cesarean delivery and cesarean hysterectomy. In: Williams Obstetrics, 22nd edition. Appleton & Lange, Stamford: 2005.
6. Hansch E, Chitkara U, McAlpine J, et al: Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 1999; 180(6):1454-60.
Only gold members can continue reading.
Log In or
Register to continue
Related
Full access? Get Clinical Tree